Merck KGaA Sells Pithiviers Production Site to Orgasynth

26-Nov-2004

In a move to consolidate its global production infrastructure, Merck KGaA has decided to sell its production site in Pithiviers, France, located 100 km south of Paris. The site will be acquired by Orgasynth SA, a Paris-based chemical company specializing in the production of fine chemicals and intermediates. Both parties signed the sale agreement today. The transaction will be closed as soon as all necessary regulatory approvals have been granted.

Under terms of the agreement, Orgasynth will take over the production site including all assets and liabilities. Of the total 94 employees, 77 will transfer to Orgasynth. The remaining 17 employees will either retire or have accepted an offer of early retirement. In addition, Orgasynth will take over the existing business and continue to produce for Merck.

The Pithiviers site was established in 1973 by Anphar Rolland Laboratories. In 1978, the plant was acquired by Lipha, at that time a subsidiary of Air Liquide. Through acquisition of Lipha in 1991, the production site became part of Merck. As part of Merck's global production network, activities in Pithiviers focused on development and production of finished products, intermediates and active pharmaceutical ingredients used by several businesses of Merck.

"With this move, we further optimize our global production network to remain competitive and we are able to secure employment for the majority of employees," said Elmar Schnee, President of Merck Santé in France.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!